U.S. General Merchandise and Department Stores Stock News

Constellation Brands (STZ) has drawn fresh attention after first quarter results showed lower sales but higher net income and earnings per share, alongside continued buybacks, a quarterly dividend and new index inclusions. See our latest analysis for Constellation Brands. Despite the solid first quarter earnings beat and continued buybacks, Constellation Brands’ share price has fallen 20.1% over the past three months to US$130.34, and the 1 year total shareholder return has declined 20.8%...

Uranium Energy stock has delivered a very strong 364.0% return over the past 5 years, yet its current valuation checks and premium market multiples suggest the shares are no longer an obvious bargain. A roughly 5 year return of 364.0% points to a stock that has already priced in a lot of optimism about Uranium Energy's future cash generation. The push into U.S. in situ recovery production and a proposed uranium refining and conversion facility can support long term earnings potential, while...

Wave Life Sciences stock has had a tough start to 2026, with a sharp year to date decline set against valuation checks that point to a stock that still looks expensive on traditional measures. Year to date, Wave Life Sciences is down 60.9%, which means recent gains over the past week and month have not yet repaired the earlier damage. Recent progress on its US redomiciliation and RNA programs for obesity and alpha-1 antitrypsin deficiency can support higher growth expectations, but execution...

Ameresco stock has delivered a steep 59.5% decline over the past five years, yet current valuation checks send mixed signals, with the Discounted Cash Flow (DCF) intrinsic value pointing to a premium while earnings-based multiples suggest the shares could be on the cheap side. Over the past 5 years, Ameresco shares are down 59.5%, which sets a cautious backdrop for any argument that the current price already bakes in a recovery story. The prospect of tighter rules on foreign power inverters...

On June 30, 2026, Kingsoft Cloud Holdings Limited shareholders approved amendments to its Second Amended and Restated Memorandum and Articles of Association, adopting a Third Amended and Restated version while confirming its authorized share capital remained at US$40,000,000 with 40,000,000,000 authorized shares and 4,531,784,801 issued shares. Morgan Stanley has now begun covering Kingsoft Cloud with an Overweight rating, framing the Chinese AI cloud provider’s growth prospects through its...

ZTO Express (Cayman) (ZTO) is back in focus after Zacks raised its consensus estimate for the company’s current year earnings by 6.8% over the past two months, highlighting its income profile. See our latest analysis for ZTO Express (Cayman). At a share price of US$23.22, ZTO Express (Cayman) has posted an 8.20% year to date share price return and a 35.23% total shareholder return over the past year. The recent 30 day share price gain of 5.07% contrasts with a 90 day decline of 5.11%,...

Casella Waste Systems has appointed Damian Ribar as Executive Vice President and Chief Operating Officer, effective July 20, 2026, and promoted longtime legal leader Shelley Sayward to Executive Vice President and General Counsel, expanding its senior leadership bench. These moves bring in a seasoned operator with deep acquisition-integration experience while elevating a key internal leader who oversees legal, regulatory, and risk functions central to Casella’s expansion plans. We’ll now...

Insiders who acquired US$2.65m worth of The Metals Royalty Company Inc.'s ( NASDAQ:TMCR ) stock at an average price of...

First Watch Restaurant Group, Inc. ( NASDAQ:FWRG ), might not be a large cap stock, but it saw a significant share...

Over the last 7 days, the United States market has remained flat, yet it has experienced an impressive 18% growth over the past year with earnings forecasted to grow by another 18% annually. In this environment, identifying stocks that are potentially undervalued compared to their intrinsic value can offer investors opportunities for growth that align with these optimistic market conditions.

The market remained flat over the last week, but has shown a robust 18% increase over the past year, with earnings projected to grow by the same percentage annually. In this environment, identifying growth companies with substantial insider ownership can be particularly appealing as it often signals confidence from those closest to the business.

In the last week, the market has stayed flat, though it is up 18% over the past year and earnings are forecast to grow by 18% annually. Penny stocks may be a throwback term, but the opportunities they represent are far from old news. These smaller or newer companies can offer growth potential at lower price points, especially when backed by strong financial health and solid fundamentals.

In the last week, the United States market has stayed flat, but over the past 12 months, it has risen by an impressive 18%, with earnings forecasted to grow annually at a similar rate. In this environment, dividend stocks that offer substantial yields can be appealing for investors seeking consistent income alongside potential capital appreciation.

The recent price decline of 11% in Bonk, Inc.'s ( NASDAQ:BNKK ) stock may have disappointed insiders who bought...

Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) value has fallen 12% in the last week, but insiders who sold US$220k worth...

Curbline Properties (CURB) recently completed a follow on equity offering, issuing 10,000,000 common shares for total proceeds of $308.5 million. This transaction reshapes its capital base and potential dilution profile. See our latest analysis for Curbline Properties. Since listing, Curbline Properties has seen solid momentum, with a year to date share price return of 31.86% and a 1 year total shareholder return of 40.88%. The recent follow on offering price of $30.85 sits close to the...

Encompass Health stock sits at a point where a solid 5 year return record meets a valuation setup that screens as attractively priced, with both intrinsic value estimates using a Discounted Cash Flow (DCF) approach and market multiples pointing to the shares trading below what the cash flows may justify. Over the past 5 years, Encompass Health has returned 83.0%, which puts recent short term swings into the context of a stock that has already rewarded patient holders. Investor interest tied...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

AMC Entertainment Holdings (NYSE:AMC) is launching Arena One, a live concerts platform, across more than 300 U.S. theaters. The rollout turns AMC locations into multi-purpose venues, hosting live music events in addition to traditional movie screenings. The company is positioning Arena One as a way to broaden its entertainment offering and open up additional revenue channels. AMC Entertainment Holdings is known primarily for its movie theaters, but Arena One signals a push to use those...

Insight Enterprises stock is up 34.0% year to date, yet the valuation picture is more balanced, with a Discounted Cash Flow (DCF) intrinsic value estimate that sits close to the current price while earnings-based multiples still screen the shares as undervalued. The 34.0% year to date gain suggests investors have already repriced Insight Enterprises positively, so any further upside may depend on how much earnings and cash flow can improve from here. Expectations for ongoing cash generation...

SPX Technologies stock has delivered a very strong 235.7% return over the past five years, yet the valuation signals are split, with a Discounted Cash Flow (DCF) estimate pointing to roughly 23.2% upside to intrinsic value while earnings multiples paint a richer picture. Over five years, SPX Technologies has returned 235.7%, which puts extra focus on whether the recent share price now builds in most of the good news. Growing data center cooling demand in the HVAC segment can support higher...

Waters Corporation (NYSE:WAT) has expanded its role in at-home cervical cancer screening through the acquisition of BD Biosciences and BD Diagnostic Solutions. The acquired diagnostics and biosciences platforms are now enabling SNT Biotech's nationwide self-collection solution for cervical cancer tests. This move connects Waters' lab and diagnostics capabilities directly to a public health initiative aimed at improving access for underserved populations. Waters enters this development with...

Markets are wrestling with a split Federal Reserve, persistent inflation risks, and a new leadership style that offers far less guidance, which can punish companies that rely on cheap capital and reward those with sturdier balance sheets. Against that backdrop, data center infrastructure and semiconductor hardware stocks tied to artificial intelligence sit right in the crosshairs of policy uncertainty and heavy corporate investment. This article looks at 3 stocks from our AI and Data Center...

Teva Pharmaceutical Industries (NYSE:TEVA) is advancing TEV-408, an anti-IL-15 monoclonal antibody for vitiligo, into a Phase 2b trial following encouraging Phase 1b data. The Phase 1b study reported improvements in skin pigmentation along with a favorable safety profile, supporting continued development. The move targets an area where systemic treatment choices for vitiligo remain limited, addressing a clear medical need. For investors tracking Teva Pharmaceutical Industries, the focus now...